Skip to main content

Table 3 Multivariable survival analysis with immune metagenes in the high proliferation tertile.

From: Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis

PH(n= 657) Multivariate
Variables Hazard ratio
(95% CI)2
P- value3
Model 1
B/P (L, I, H)1 0.72 (0.58 to 0.89) 0.003
T/NK (L, I, H) 0.73 (0.59 to 0.90) 0.003
Model 2
B/P (L, I, H) 0.73 (0.62 to 0.89) 0.002
M/D (L, I, H) 0.70 (0.57 to 0.85) 0.0004
Model 3
T/NK (L, I, H) 0.77 (0.60 to 0.99) 0.04
M/D (L, I, H) 0.70 (0.55 to 0.90) 0.006
Model 4
B/P (L, I, H) 0.76 (0.61 to 0.94) 0.01
M/D (L, I, H) 0.75 (0.58 to 0.97) 0.03
T/NK (L, I, H) 0.88 (0.67 to 1.15) 0.34
  1. 1metagene tertiles (L: low; I: intermediate; H: high); 2 95%. B/P: B cell/plasma cell metagene; M/D: monocytes and dendritic cell metagene; T/NK: T cell and natural killer cell metagene.